학술논문
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses
Document Type
Article
Author
Kelly, R.J.; Landon, B.V.; Singh, D.; Canzoniero, J.V.; Balan, A.; Hales, R.K.; Voong, K.R.; Marrone, K.A.; Pereira, G.; Rao, N.; Borole, A.; Karaindrou, K.; Belcaid, Z.; White, J.R.; Ke, S.; Smith, K.N.; Pardoll, D.M.; Hu, C.; Feliciano, J.L.; Anagnostou, V.; Lam, V.K.; Zaidi, A.H.; Jobe, B.A.; Amjad, A.I.; Weksler, B.; Battafarano, R.J.; Yang, S.C.; Broderick, S.; Ha, J.; Shin, E.J.; Thompson, E.
Source
In: Nature Medicine . (Nature Medicine, April 2024, 30(4):1023-1034)
Subject
Language
English
ISSN
1546170X
10788956
10788956